Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 250,000 shares at $6.06 ($1.5M) on 2008-03-20, disclosed to the SEC on 2008-03-24.
Open-market sale of $1.5M HALO by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |